Skip to main content
Clinical Trials/CTRI/2014/08/004866
CTRI/2014/08/004866Not yet recruitingPhase 3

Role of zinc supplementation on acute inflammatory response and outcome in neonatal sepsis - a randomized controlled trial.

I0 sites75 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Enrollment
75

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Gestational age >= 32weeks
  • 2. Age < 28 days
  • 3. Babies on enteral feeds.
  • 4. Clinically diagnosed sepsis with at least two screening tests positive such as mESR, CRP and band cell count or positive blood culture.

Exclusion Criteria

  • 1. Surgical conditions and major congenital malformations.
  • 2. Apgar score < 6 at 5 min
  • 3. Neonates who are already on treatment for sepsis.

Investigators

Sponsor
I

Similar Trials